BSECompany Update15h ago · 14 Oct 2026, 06:40 pm
Please find enclosed herewith the disclosure under Regulation 31A (10) of the SEBI Regulations in relation to re-classification from the "promoter and promoter Group category" to the "public" category
Bliss GVS Pharma Ltd · 506197
✦ AI SummaryPromoter Reclassif.
Bliss GVS Pharma Ltd has re-classified from 'promoter and promoter group' to 'public' category after Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited acquired control of the company. The updated list of promoters and promoter groups is provided.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bliss GVS Pharma Ltd - 506197 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
Attachments (1)
📄pdf
Download →
143bec2d-2ac6-4f63-9974-69e7b2510928.pdf
View document text
October 14, 2026
To To
The Manager, Listing Department The General Manager, Listing Department
National Stock Exchange of India Limited BSE Limited
Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (East), Dalal Street,
Mumbai- 400 051 Mumbai- 400 001
Symbol: BLISSGVS Scrip Code: 506197
Dear Sir/Madam,
Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").
Ref: Disclosure Submitted to Stock Exchanges on September 28, 2026 under Regulation
31A(10) of the SEBI Listing Regulations in relation to re-classification from the “promoter
and promoter group” category to the “public” category.
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing
Regulations”), we wish to inform you that, consequent upon the consummation of the
transaction contemplated under the Share Purchase Agreement dated May 23, 2026 (“SPA”),
read with the relevant transaction documents, on September 28, 2026, and completion of the
open offer in accordance with the Securities and Exchange Board of India (Substantial
Acquisition of Shares and Takeovers) Regulations, 2011, Anupam Rasayan India Limited and
Mates Visa Consultancy Private Limited acquired control of Bliss GVS Pharma Limited
(“Company”) and classified as Promoters of the Company.
Consequent to the aforesaid transaction and the change in control of the Company, the Board
of Directors of the Company, at its meeting held on September 28, 2026, took note of the
reclassification of the erstwhile Promoters and Promoter Group from the “Promoter and
Promoter Group” category to the “Public” category in accordance with Regulation 31A(10) of
the SEBI Listing Regulations.
Accordingly, the updated list of Promoters and Promoter Group of the Company, pursuant
to the aforesaid transaction, is set out below:
No. Entity Category
1 Anupam Rasayan India Limited Promoter
2 Mates Visa Consultancy Pvt. Ltd. Promoter
3 Kiran Pallavi Investments LLC Promoter Group
4 Jainam Intermediates Pvt. Ltd. Promoter Group
5 ARIL Transmodal Logistic Pvt. Ltd. Promoter Group
6 ARIL Fluorospeciality Pvt. Ltd. Promoter Group
7 Anupam Japan GK Promoter Group
8 Anupam Europe AG Promoter Group
9 Anupam USA, LLC Promoter Group
10 Anupam General Trading FZE Promoter Group
11 Doriath S.A.R.L. Promoter Group
12 Kansas HoldCo Inc. Promoter Group
13 Kansas HoldCo 1, Inc. Promoter Group
14 Jayhawk Fine Chemicals Corporation Promoter Group
15 Tanfac Industries Limited Promoter Group
Kindly take the above information on your record and acknowledge.
Thanking you,
Yours Faithfully,
For Bliss GVS Pharma Limited
Aditi Bhatt
Company Secretary & Compliance Officer